Date of Award
Doctor of Nursing Practice (DNP)
Dr. Hilary Morgan
Dr. Paul Rotert
Practice Problem: Human Immunodeficiency Virus (HIV) is one of the leading pandemics in the world. In 2019, 38 million people were living with HIV around the world. Of those, roughly 87% were aware of their HIV status.
PICOT: In patients with high risk for HIV, how does implementing a pre-exposure (PrEP) screening tool compared to randomly screening for pre-exposure prophylaxis (PrEP) affect the prescribing of pre-exposure prophylaxis (PrEP) within eight weeks?
Evidence: In 2015, the World Health Organization (WHO) recommended PrEP for the prevention of HIV in high-risk individuals. The patients include men who have sex with men, sex workers, individuals with multiple sex partners, and intravenous drug users. In 2021, only about 25% of individuals with high-risk for HIV are utilizing PrEP.
Intervention: There are two interventions in this research: PrEP screening tool and prescription of PrEP.
Outcome: An increase in the number of those screened for the use of PrEP increased dramatically from previous screening. Although the percentage goal of those prescribed PrEP was not met, there was an increase in those prescribed PrEP compared to previous prescribing methods.
Conclusion: In conclusion, the use of a PrEP screening tool in general practice can increase the use of PrEP in high-risk populations. The best way to stop the HIV pandemic is to utilize the best prevention available, which is PrEP. Using a PrEP screening tool in clinics not knowledgeable on PrEP will increase the prescribing of PrEP.
Hall, C. (2022). Increasing the Prescribing of Pre-Exposure Prophylaxis (PrEP) With a Pre-Exposure Prophylaxis Screening Tool. [Doctoral project, University of St Augustine for Health Sciences]. SOAR @ USA: Student Scholarly Projects Collection. https://doi.org/10.46409/sr.ZIXA9889
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.